<DOC>
	<DOCNO>NCT00627016</DOCNO>
	<brief_summary>The purpose study determine whether Dexlansoprazole daily ( QD ) effective treat patient night heartburn .</brief_summary>
	<brief_title>A Study Dexlansoprazole Modified Release Formulation Treat Night Heartburn</brief_title>
	<detailed_description>This 4 week study Dexlansoprazole ( TAK-390MR ) conduct approximately 50 investigator United States patient suffer night heartburn .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<criteria>Females childbearing potential sexually active must agree use adequate contraception , neither pregnant lactating Screening throughout duration study . History nocturnal heartburn GERD associate sleep disturbance prior screen . Meets follow criterion : 1 ) nocturnal heartburn severity moderate , severe , severe least 3 7 night ; 2 ) GERD related sleep disturbance least 3 7 night . Subjects must history symptomatic GERD prior screen GERD symptom responsive acidsuppressive therapy . Erosive esophagitis visualize screen endoscopy . Allergy proton pump inhibitor drug ( lansoprazole , omeprazole , rabeprazole , pantoprazole , esomeprazole ) , component Dexlansoprazole , Gelusil/antacid . Active gastric duodenal ulcer within 30 day prior randomization . Upper gastrointestinal bleeding within 6 month prior randomization . Coexisting disease affect esophagus ( eg , eosinophilic esophagitis , esophageal varix , scleroderma , viral fungal infection , and/or Barrett 's esophagus ) . History radiation therapy cryotherapy esophagus , caustic physiochemical trauma sclerotherapy esophagus . Subject require dilation esophageal strictures and/or stricture prevent passage endoscope screen endoscopy . Schatzki 's ring ( ring mucosal tissue near low esophageal sphincter ) acceptable . Has another condition could primary cause subject 's sleep disturbance . Evidence uncontrolled , clinically significant neurologic , cardiovascular , pulmonary , hepatic , renal , metabolic , gastrointestinal , endocrine disease abnormality ( disease study ) may impact ability subject participate potentially confound trial result . Diagnosis cancer ( except basal cell carcinoma ) within 5 year screen . Has condition likely require surgery study . Currently diagnose acquire immunodeficiency syndrome ( AIDS ) . Abnormal clinical laboratory value . History alcoholism drug addiction . Subject work night shift . Subject plan travel beyond 3 time zone study . Chronic use ( 12 doses/month ) nonsteroidal antiinflammatory drug ( NSAIDs ) , include cyclooxygenase2 ( COX 2 ) inhibitor within 30 day prior randomization anticipate use study . Use follow medication 14 day prior randomization anticipate use study : proton pump inhibitor , sucralfate , misoprostol , corticosteroid , prokinetics , anticoagulant therapy , antiseizure medication ( stable dos ) , psychotropic medication ( stable dos ) , narcotic medication ( occasional use allow ) , bisphosphonates . Use sleep medication , first generation antihistamine , benzodiazepine , modify cyclic antidepressant , antianxiety medication drug significant anticholinergic effect tricyclic antidepressant drug central nervous system effect could mask perception symptom ( eg , selectiveserotonin reuptake inhibitor , serotonin norepinephrine reuptake inhibitor ) . However , subject remain stable regimen dose medication 90 day prior randomization agree maintain regimen dose trial qualify . Also , short term use anticholinergic trial related procedure exclusionary . Second generation antihistamine exclude . Use histamine ( H2 ) receptor antagonist antacid ( except trial supply Gelusil ) screen period anticipate use treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Non-Erosive Gastroesophageal Reflux Disease</keyword>
	<keyword>GERD</keyword>
	<keyword>heartburn</keyword>
	<keyword>sleep disturbance</keyword>
	<keyword>nocturnal Reflux</keyword>
</DOC>